Anish A. Shah, MD
MD, Medical College of Virginia, Virginia Commonwealth University School of Medicine
Obstetrics and Gynecology, Duke University Medical Center
Reproductive Endocrinology, Duke University Medical Center
Master of Health Science in Clinical Research with a focus in Cost Effectiveness and Health Economics, Duke University
Clinical and Treatment Interests
Patient centered care, assisted reproduction technologies, recurrent pregnancy loss, reproductive tract abnormalities, polycystic ovary syndrome, endometriosis, uterine fibroids, advance laparoscopic surgery, clinical research, cost effectiveness, health economics, improving fertility coverage
I believe in patient-centered care trying to teach other infertility specialists methods to best counsel patients effectively and in an informed manner. I also am very passionate about improving the safety of in vitro fertilization and its access to all patients. My research, therefore, has focused in reducing ovarian hyperstimulation syndrome (OHSS), creating sophisticated models that try to improve safety in assisted reproductive technologies and models that try to improve access to IVF by insurance carriers. I am also a fellow at the Agency for Healthcare Research and Quality which is funded by the Department of Health and Human Services whose mission is to improve quality of care given in medicine.
I have received a prestigious Agency for Healthcare Research and Quality National Research Service Award and the Society for Gynecologic Investigation award for best new investigator in addition to numerous teaching awards.
Prize Abstracts and Papers
Brezina PR, Shah AA, Myers ER, Huang A, DeCherney AH. The evolving impact of health policy on the delivery of health care as it pertains to reproductive endocrinology and infertility in the United States. Semin Reprod Med. 2012 Aug; accepted.
Crochet JR, Shah AA, Schomberg DW, Price TM. Hyperglycosylated human chorionic gonadotropin doesnot increase progesterone production by luteinized granulosa cells. JCEM. 2012 Sept; accepted.
Steward RG, Saleh OA, James AH, Shah AA, Price TM. Management of gynecologic surgery in the patient with factor XI deficiency: A review of the literature. Obstet Gynecol Surv. 2012 May;67(5): 291-7.
Yeh JS, Shah AA, Myers ER, Price TM, Wu JM. Assisted reproductive technology in the United States: recent trends and predictions for the future. American College of Obstetrics and Gynecology, 59th Annual Clinical Meeting. Abstract Apr 2011.
Yeh JS, Shah AA, Myers ER, Price TM, Wu JM. Assisted reproductive technology in the United States: recent trends and predictions for the future. N.C. Obstetrical and Gynecological Society, 2011 Annual Meeting. Abstract Apr 2011.
Shah AA, Miller S, Dai Q, Price TM. Localization of a novel truncated progesterone receptor, PR-M, to the outer mitochondrial membrane in human myometrial tissue. Society for Gynecologic Investigation, 57th Annual Meeting. Abstract Mar 2010.
Shah AA, Walmer DK. A feasibility study to evaluate pelvic peritoneal anatomy with a saline intraperitoneal sonogram (SIPS). Fertil Steril. 2010 Dec; 94(7):2766-8.
Shah AA, Likes CE, Price TM. Early polycystic ovary syndrome as a possible etiology of unexplained premenarcheal ovarian torsion. J Pediatr Adolesc Gynecol. 2009 Aug; 22(4):265-9.
Shah AA, Grotegut CA, Likes CE, Miller MJ, Walmer DK. Heterotopic cervical pregnancy treated with transvaginal ultrasound-guided aspiration resulting in cervical site varices within the myometrium. Fertil Steril. 2009 Mar; 91(3):934.e19-22.
Bland AE, Shah AA, Piscitelli JT, Bentley RC, Secord AA. Desmoplastic small round cell tumor masquerading as advanced ovarian cancer. Int J Gynecol Cancer. 2008 Jul-Aug; 18(4):847-50.
Albright CD, Klem E, Shah AA, Gallagher P. Breast cancer cell-targeted oxidative stress: enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation. Exp Mol Pathol. 2005 Oct; 79(2):118-25.
Albright CD, Shah AA, Monson RC, Bokovanov V, Salganik RI, Van Dyke T. Dietary antioxidant depletion enhances apoptosis and inhibits mammary tumorigenesis and metastasis in transgenic mice. FASEB J 2001;15:A250.